Autolog stamcellebehandling til patienter med multipel sklerose

Freja Jespersen; Anne Fischer-Nielsen; Søren Lykke Petersen; Morten Blinkenberg

Autolog stamcellebehandling til patienter med multipel sklerose

Freja Jespersen, Anne Fischer-Nielsen, Søren Lykke Petersen, Morten Blinkenberg

Abstract

Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.

Bidragets oversatte titel	Autologous haematopoietic stem cell transplantation of patients with multiple sclerosis
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	181
Udgave nummer	36
Sider (fra-til)	V03190186
ISSN	0041-5782
Status	Udgivet - 2 sep. 2019

Citationsformater

@article{fbde97c30025450993fdbb0194a46682,

title = "Autolog stamcellebehandling til patienter med multipel sklerose",

abstract = "Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.",

author = "Freja Jespersen and Anne Fischer-Nielsen and Petersen, {S{\o}ren Lykke} and Morten Blinkenberg",

year = "2019",

month = sep,

day = "2",

language = "Dansk",

volume = "181",

pages = "V03190186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "36",

}

TY - JOUR

T1 - Autolog stamcellebehandling til patienter med multipel sklerose

AU - Jespersen, Freja

AU - Fischer-Nielsen, Anne

AU - Petersen, Søren Lykke

AU - Blinkenberg, Morten

PY - 2019/9/2

Y1 - 2019/9/2

N2 - Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.

AB - Immunosuppression with chemotherapy followed by autologous haematopoietic stem cell transplantation has proven to be an effective long-term treatment for younger patients with relapsing-remitting multiple sclerosis and clinical as well as radiological evidence of high disease activity. The conditioning regimen can be of either high, intermediate or low intensity. Due to the safety profile and favourable efficacy measures, the low intensity regimen cyclophosphamide + anti-thymocyte globulin is currently used in Denmark as standard regimen.

M3 - Tidsskriftartikel

C2 - 31538572

SN - 0041-5782

VL - 181

SP - V03190186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 36

ER -

Autolog stamcellebehandling til patienter med multipel sklerose

Abstract

Fingeraftryk

Citationsformater